NeuroSense Therapeutics Ltd. Increase (Decrease) in Accounts and Other Receivables
NeuroSense Therapeutics Ltd. (NRSN) reported Increase (Decrease) in Accounts and Other Receivables of -$424.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables · last filed 2026-03-31
| Period end | Increase (Decrease) in Accounts and Other Receivables 6 month | Increase (Decrease) in Accounts and Other Receivables 12 month |
|---|---|---|
| 2025-12-31 | -$424.00K 20-F · filed 2026-03-31 | |
| 2025-06-30 | -$141.00K 6-K · filed 2025-08-01 | |
| 2024-12-31 | $753.00K 20-F · filed 2026-03-31 | |
| 2024-06-30 | $140.00K 6-K · filed 2025-08-01 | |
| 2023-12-31 | -$19.00K 20-F · filed 2026-03-31 |